gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 08 Dec 2016.

B-cell CLL/lymphoma 9-like

BCL9L, BCL9-2
Papers on BCL9L
BCL9-2 promotes early stages of intestinal tumor progression.
GeneRIF
Birchmeier et al., Berlin, Germany. In Gastroenterology, 2011
BCL9-2 promotes early phases of intestinal tumor progression in humans and in transgenic mice. BCL9-2 increases the expression of a subset of canonical Wnt target genes but also regulates genes that are required for early stages of tumor progression.
Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway.
GeneRIF
Akiyama et al., Tokyo, Japan. In Nat Commun, 2010
Data show that the GCM1/syncytin-B pathway is significantly downregulated in the placenta of BCL9L-deficient mice and that the fusion and differentiation of ST-II cells are blocked.
Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor.
GeneRIF
Bienz et al., Cambridge, United Kingdom. In J Mol Biol, 2010
Pygo2 PHD is the only known PHD finger that is capable of interacting simultaneously with two functional ligands, B9L and BCL9.
Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
GeneRIF
Akiyama et al., Maebashi, Japan. In Cancer Sci, 2007
We demonstrated that nuclear B9L expression was closely associated with the high nuclear grade cancer phenotype and the expression of ErbB2/HER-2 in breast cancers.
Crystal structure of a beta-catenin/BCL9/Tcf4 complex.
GeneRIF
Xu et al., Seattle, United States. In Mol Cell, 2006
crystallographic analysis of how beta-catenin, BCL9, BCL9-2 and Tcf4 interact
share on facebooktweetadd +1mail to friends